Nextgen Biomed Ltd (TLV:NXGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 48.70
+0.30 (0.62%)
At close: Sep 30, 2025
Nextgen Biomed Market Cap
Nextgen Biomed has a market cap or net worth of 7.21 million as of December 5, 2025. Its market cap has increased by 10.23% in one year.
Market Cap
7.21M
Enterprise Value
7.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48.70
Market Cap Chart
Since July 17, 2013, Nextgen Biomed's market cap has decreased from 18.97M to 7.21M, a decrease of -62.01%. That is a compound annual growth rate of -7.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 103.27B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.32B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.05B |
| SofWave Medical | 1.01B |
| Ilex Medical | 718.16M |
| Novolog (Pharm-Up 1966) | 653.92M |